SK498A3 - Macrolides, a method for their preparation and a pharmaceutical composition containing the same - Google Patents
Macrolides, a method for their preparation and a pharmaceutical composition containing the same Download PDFInfo
- Publication number
- SK498A3 SK498A3 SK4-98A SK498A SK498A3 SK 498 A3 SK498 A3 SK 498A3 SK 498 A SK498 A SK 498A SK 498 A3 SK498 A3 SK 498A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- macrolide
- compound
- ring
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9513596.8A GB9513596D0 (en) | 1995-07-04 | 1995-07-04 | Organic compounds |
| GBGB9515495.1A GB9515495D0 (en) | 1995-07-28 | 1995-07-28 | Organic compounds |
| PCT/EP1996/002952 WO1997002285A1 (en) | 1995-07-04 | 1996-07-04 | Macrolides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK498A3 true SK498A3 (en) | 1998-07-08 |
Family
ID=26307320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK4-98A SK498A3 (en) | 1995-07-04 | 1996-07-04 | Macrolides, a method for their preparation and a pharmaceutical composition containing the same |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0836616A1 (cs) |
| JP (1) | JPH11509092A (cs) |
| KR (1) | KR19990028724A (cs) |
| CN (1) | CN1193979A (cs) |
| AR (1) | AR006514A1 (cs) |
| AU (1) | AU708004B2 (cs) |
| BR (1) | BR9609324A (cs) |
| CA (1) | CA2224715A1 (cs) |
| CO (1) | CO4750713A1 (cs) |
| CZ (1) | CZ424297A3 (cs) |
| HU (1) | HUP9802320A3 (cs) |
| IL (1) | IL122844A0 (cs) |
| NO (1) | NO980016L (cs) |
| PL (1) | PL324346A1 (cs) |
| SK (1) | SK498A3 (cs) |
| TR (1) | TR199800001T1 (cs) |
| WO (1) | WO1997002285A1 (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124453A (en) * | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
| GB9811854D0 (en) * | 1998-06-02 | 1998-07-29 | Ciba Geigy Ag | Organic compounds |
| US7368423B1 (en) * | 2001-12-05 | 2008-05-06 | The Scripps Research Institute | Composition and method for treating chronic allograft rejection |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| CN101242842A (zh) | 2005-06-17 | 2008-08-13 | 诺瓦提斯公司 | Sanglifehrin在hcv中的用途 |
| US8067024B2 (en) | 2006-02-10 | 2011-11-29 | Medtronic Vascular, Inc. | Medical devices to prevent or inhibit restenosis |
| CN101289440B (zh) * | 2007-06-29 | 2010-08-25 | 中国热带农业科学院热带生物技术研究所 | 一种多烯大环类化合物及其制备方法与应用 |
| ES2556211T3 (es) * | 2008-09-24 | 2016-01-14 | Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences | Agrupación de genes novedosa |
| WO2011098805A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| WO2011098808A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| WO2011098809A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| GB201008123D0 (en) | 2010-05-17 | 2010-06-30 | Biotica Tech Ltd | Novel compounds |
| UY33775A (es) | 2010-12-10 | 2012-07-31 | Gilead Sciences Inc | Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos |
| EP2654753B1 (en) * | 2010-12-20 | 2018-10-31 | Neurovive Pharmaceutical AB | Sanglifehrin derivatives and methods for their production |
| JO3063B1 (ar) | 2011-03-29 | 2017-03-15 | Neurovive Pharmaceutical Ab | مركب مبتكر وطرق لانتاجه |
| GB201118334D0 (en) | 2011-10-24 | 2011-12-07 | Biotica Tech Ltd | Novel dosage form |
| AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| CA2875692A1 (en) * | 2012-06-08 | 2013-12-12 | Selcia Limited | Macrocyclic inhibitors of flaviviridae viruses |
| PL2859009T3 (pl) * | 2012-06-08 | 2018-03-30 | Gilead Sciences, Inc. | Makrocykliczne inhibitory wirusów flaviviridae |
| CA3043131A1 (en) | 2016-11-18 | 2018-05-24 | Neurovive Pharmaceutical Ab | Use of sanglifehrin macrocyclic analogues as anticancer compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318144D0 (en) * | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
| WO1995015328A1 (en) * | 1993-11-30 | 1995-06-08 | Abbott Laboratories | Macrocyclic immunomodulators with novel cyclohexyl ring replacements |
-
1996
- 1996-07-03 AR ARP960103427A patent/AR006514A1/es unknown
- 1996-07-04 CO CO96034982A patent/CO4750713A1/es unknown
- 1996-07-04 SK SK4-98A patent/SK498A3/sk unknown
- 1996-07-04 KR KR1019980700022A patent/KR19990028724A/ko not_active Application Discontinuation
- 1996-07-04 TR TR1998/00001T patent/TR199800001T1/xx unknown
- 1996-07-04 CN CN96196487A patent/CN1193979A/zh active Pending
- 1996-07-04 HU HU9802320A patent/HUP9802320A3/hu unknown
- 1996-07-04 BR BR9609324A patent/BR9609324A/pt not_active Application Discontinuation
- 1996-07-04 PL PL96324346A patent/PL324346A1/xx unknown
- 1996-07-04 WO PCT/EP1996/002952 patent/WO1997002285A1/en not_active Application Discontinuation
- 1996-07-04 AU AU65193/96A patent/AU708004B2/en not_active Ceased
- 1996-07-04 IL IL12284496A patent/IL122844A0/xx unknown
- 1996-07-04 CA CA002224715A patent/CA2224715A1/en not_active Abandoned
- 1996-07-04 CZ CZ974242A patent/CZ424297A3/cs unknown
- 1996-07-04 EP EP96924886A patent/EP0836616A1/en not_active Withdrawn
- 1996-07-04 JP JP9504832A patent/JPH11509092A/ja active Pending
-
1998
- 1998-01-02 NO NO980016A patent/NO980016L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997002285A1 (en) | 1997-01-23 |
| EP0836616A1 (en) | 1998-04-22 |
| AU6519396A (en) | 1997-02-05 |
| HUP9802320A2 (hu) | 1999-02-01 |
| IL122844A0 (en) | 1998-08-16 |
| HUP9802320A3 (en) | 1999-03-29 |
| MX9800217A (es) | 1998-07-31 |
| AR006514A1 (es) | 1999-09-08 |
| KR19990028724A (ko) | 1999-04-15 |
| JPH11509092A (ja) | 1999-08-17 |
| CN1193979A (zh) | 1998-09-23 |
| TR199800001T1 (xx) | 1998-04-21 |
| NO980016L (no) | 1998-03-02 |
| BR9609324A (pt) | 1999-05-25 |
| PL324346A1 (en) | 1998-05-25 |
| AU708004B2 (en) | 1999-07-29 |
| NO980016D0 (no) | 1998-01-02 |
| CO4750713A1 (es) | 1999-03-31 |
| CZ424297A3 (cs) | 1998-04-15 |
| CA2224715A1 (en) | 1997-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6124453A (en) | Macrolides | |
| SK498A3 (en) | Macrolides, a method for their preparation and a pharmaceutical composition containing the same | |
| LONGLEY et al. | DISCODERMOLIDE—A NEW, MARINE-DERIVED IMMUNOSUPPRESSIVE COMPOUND: II. IN VIVO STUDIES | |
| US4914188A (en) | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin | |
| US5227467A (en) | Immunosuppressive fluorinated cyclosporin analogs | |
| JPH06234737A (ja) | 免疫抑制剤としての新規なアミノメチレン−ペプチド類 | |
| JPH09503507A (ja) | 免疫抑制活性を有するｏ−アリール、ｏ−アルキル、ｏ−アルケニル及びｏ−アルキニルマクロライド | |
| JPH0372484A (ja) | トリシクロ化合物 | |
| JPH05194530A (ja) | 免疫抑制活性を有するフルオロマクロライド | |
| WO2006012204A2 (en) | Method for treatment of inflammatory disorders using triptolide compounds | |
| US4681880A (en) | Use of thio isosteres of ergot peptide alkaloids as vasaconstrictors | |
| CA2612482A1 (en) | Biologically active compounds obtainable from sorangium cellulosum | |
| KR101694879B1 (ko) | 면역억제활성 없이 신경재생활성이 유지되는 fk506 유도체 및 그의 용도 | |
| IL91708A (en) | Peptolides containing pipecolic acid, their preparation and pharmaceutical preparations containing them | |
| WO1995006649A1 (en) | Macrolides as antagonists of macrophilin binding immunosuppressants | |
| JP4029137B2 (ja) | 新生理活性物質 | |
| US5298523A (en) | Method for treating transplant patients using mycalamide compounds | |
| JPH05117279A (ja) | 免疫抑制剤、抗炎症剤または抗真菌剤用ラパマイシンの還元生成物 | |
| AU775414B2 (en) | New indolocarbazole alkaloids from a marine actinomycete | |
| JPH06271533A (ja) | 免疫抑制剤としての新規なアミノメチレン誘導体 | |
| CA2237157C (en) | Cyclopeptolide inhibitors of adhesion molecules | |
| MXPA98000217A (en) | Macroli | |
| KR20160067079A (ko) | 면역억제활성 없이 신경재생활성이 유지되는 fk506 유도체 및 그의 용도 | |
| Bin et al. | Alkaloids from the Jellyfish-Derived Fungus Aspergillus fumigatus SCSIO41214 | |
| NZ290430A (en) | Tetracyclic triterpenes |